Jeff Goh Clinical Oncology Society of Australia Annual Scientific Meeting 2021

Jeff Goh

Adjunct Professor Jeffrey C Goh (MBBS, FRACP) Senior Medical Oncologist (part-time), Royal Brisbane & Women’s Hospital. VMO Oncologist ICON Chermside & Greenslopes Private Hospital Dr Jeffrey Goh is an experienced Medical Oncologist consulting at Icon Cancer Centre Chermside and Greenslopes Private Hospital. In 1996, he completed his Bachelor of Medicine, Bachelor of Surgery at Monash University and worked in Adelaide graduating. He moved from Adelaide to Brisbane to pursue training in Haematology & Oncology in 2002. Dr Goh subsequently held a position as a laboratory and Clinical Haematology registrar at the Princess Alexandra Hospital in 2003. He completed his FRACP exams in 2004 and subsequently completed three years of advanced specialist Medical Oncology training in Brisbane and became a Fellow of the Royal Australasian College of Physicians (FRACP) in 2007. Dr Goh was appointed Staff Medical Oncologist at Royal Brisbane & Women’s Hospital (RBWH) in December 2008. Dr Goh commenced sessional private medical oncology practice as a Visiting Medical Officer (VMO) at Greenslopes Private Hospital (GPH) in 2008 and at Icon Cancer Centre Chermside in early 2010. Dr Goh is actively involved in numerous clinical trials and acted as principal investigator (PI) in a number of phase I, II and III gynaecological oncology, urological malignancy and early phase drug trials at RBWH, ICON & GPH. He is also a co-investigator in numerous other multi-centre clinical trials in oncology. He is also the CPI for the upcoming ANZGOG sponsored ITTACc trial. Dr Goh maintains an active interest in clinical research and is a member of several leading cancer trial groups including the Australian and New Zealand Urogenital & Prostate Cancer Trials Group (ANZUP), Australia & New Zealand Gynaecological Oncology Group (ANZGOG), American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO) and International Gynaecological Cancer Society (IGCS). He was previously a Board Member and chair of the QA Committee of the Australia & New Zealand Gynaecological Oncology Group (ANZGOG) and is the past Chair of the Cervical Cancer Tumour Type Working Group of ANZGOG. Dr Goh maintains a significant part-time role as Senior Staff Specialist at RBWH and was a Senior Lecturer at the University of Queensland; he was co-supervisor of PhD candidates at the University of Queensland. He was appointed Adjunct Professor at Queensland University of Technology (QUT) in April 2022. He is also involved with mentoring advanced trainee registrars in Medical Oncology at RBWH. Additionally, Dr Goh is a member of both the Research Committee and Medical Advisory Committee (MAC) at Icon. His clinical experience covers a broad range of solid tumour malignancies, with specific clinical and research interest in gynaecological and genitourinary cancers, in addition to early phase clinical trials.

Abstracts this author is presenting: